Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase 1”

33,260 trials

Showing 20 of 33,260 results

Early research (Phase 1)Study completedNCT02172274
What this trial is testing

BI 10773 Administered as Oral Solution to Healthy Male Volunteers

Who this might be right for
Healthy
Boehringer Ingelheim 8
Early research (Phase 1)UnknownNCT02200718
What this trial is testing

NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for Pediatric Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Immune Response BioPharma, Inc. 12
Early research (Phase 1)Study completedNCT02372097
What this trial is testing

A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg Tablets

Who this might be right for
Healthy
Takeda 24
Not applicableStudy completedNCT05257460
What this trial is testing

Closing the Loop in Adults With Type 1 Diabetes Under Free Living Conditions (AP@Home04_Phase 4)

Who this might be right for
Type 1 Diabetes
University of Cambridge 28
Early research (Phase 1)WithdrawnNCT05252520
What this trial is testing

JNJ-77474462 (Bermekimab) in Healthy Chinese Participants

Who this might be right for
Healthy
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)UnknownNCT03792724
What this trial is testing

Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors

Who this might be right for
Neoplasms
Clinica Universidad de Navarra, Universidad de Navarra 32
Early research (Phase 1)WithdrawnNCT06533280
What this trial is testing

VH3739937 Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers Including Relative Bioavailability (RBA), Optional Food Effect (FE), and Drug-drug Interaction (DDI)

Who this might be right for
HIV Infections
ViiV Healthcare
Not applicableUnknownNCT00306280
What this trial is testing

Feasibility Study of Phototherapy System to Treat H Pylori

Who this might be right for
Helicobacter Pylori
LumeRx 60
Early research (Phase 1)Study completedNCT02544880
What this trial is testing

PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaHead and Neck Cancer
Donald T. Weed, MD, FACS 16
Early research (Phase 1)Study completedNCT00076180
What this trial is testing

Hu-Mik-beta1 to Treat T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
T-Cell Large Granular Lymphocytic LeukemiaLeukemia, T-Cell Large Granular Lymphocytic
National Cancer Institute (NCI) 9
Early research (Phase 1)Study completedNCT00498979
What this trial is testing

Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers

Who this might be right for
Stage IV Melanoma
Case Comprehensive Cancer Center 22
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Early research (Phase 1)Study completedNCT01634503
What this trial is testing

Safety of GX-188E DNA Therapeutic Vaccine Administered by Electroporation to Cervical Intraepithelial Neoplasia Grade 3

Who this might be right for
Cervical Intraepithelial Neoplasia 3
Genexine, Inc. 9
Early research (Phase 1)Looking for participantsNCT02203903
What this trial is testing

Multi-institutional Prospective Research of Expanded Multi-antigen Specifically Oriented Lymphocytes for the Treatment of VEry High Risk Hematopoietic Malignancies

Who this might be right for
Relapsed/Refractory Hematopoietic Malignancies, Acute Myeloid Leukemia and MDS
Catherine Bollard 50
Testing effectiveness (Phase 2)UnknownNCT00003327
What this trial is testing

Paclitaxel in Treating Patients With Recurrent or Refractory Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Theradex 60
Early research (Phase 1)Study completedNCT02169583
What this trial is testing

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Repeat Escalating Doses of GSK1325756 Solution for Infusion, and Absolute Bioavailability Relative of an Oral Dose, in Healthy Adult Subjects

Who this might be right for
Infections, Respiratory Tract
GlaxoSmithKline 24
Testing effectiveness (Phase 2)UnknownNCT06282783
What this trial is testing

Studying Topiramate for Re-Activating the HIV-1 Reservoir

Who this might be right for
HIV-1-infectionHivHIV Infections+1 more
Erasmus Medical Center 12
Testing effectiveness (Phase 2)Ended earlyNCT02759315
What this trial is testing

Efficacy and Safety of Uprifosbuvir (MK-3682) With Ruzasvir (MK-8408) in Adults With Chronic Hepatitis C Genotype 1, 2, 3, 4, 5 or 6 Infection (MK-3682-035)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 160
Early research (Phase 1)Ended earlyNCT00351325
What this trial is testing

BMS-663513 Administered in Combination With Chemotherapy to Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced Solid Malignancies
Bristol-Myers Squibb 45
Early research (Phase 1)Study completedNCT03038776
What this trial is testing

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Who this might be right for
Influenza, Avian
Vaxine Pty Ltd 150
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation